-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 DdTSsUCneZxKlFMssHGMo1LWsOt4MsVl6zte0l6+ME3SfzRuMasLyK0ZTO/RboYp
 daYGpHbokPBfDVNXL1u8jQ==

<SEC-DOCUMENT>0001062822-09-000058.txt : 20090813
<SEC-HEADER>0001062822-09-000058.hdr.sgml : 20090813
<ACCEPTANCE-DATETIME>20090601123157
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001062822-09-000058
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20090601

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LEXICON PHARMACEUTICALS, INC./DE
		CENTRAL INDEX KEY:			0001062822
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				760474169
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		8800 TECHNOLOGY FOREST PLACE
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77381
		BUSINESS PHONE:		2818633000

	MAIL ADDRESS:	
		STREET 1:		8800 TECHNOLOGY FOREST PLACE
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77381

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXICON GENETICS INC/TX
		DATE OF NAME CHANGE:	20000126
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html>
  <head>
    <title>response06012009.htm</title>
<!-- Licensed to: Lexicon Pharmaceuticals-->
<!-- Document Created using EDGARizer 4.0.7.0 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div style="TEXT-ALIGN: center"><img src="logo.jpg" alt=""></div>
    <div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">June 1,
2009</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Securities
and Exchange Commission</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Division
of Corporate Finance</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">100 F
Street, N.E.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Washington,
D.C. 20549</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Attention:&#160;&#160;&#160;&#160;&#160;&#160;Ms.
Jennifer Riegel</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 54pt"></font>Division of Corporate
Finance</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 54pt"></font>Re:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">Lexicon Pharmaceuticals,
Inc.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 90pt"></font>Preliminary Proxy Statement on Schedule
14A filed May 22, 2009</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 90pt"></font>File
Number:&#160;&#160;000-30111</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear Ms.
Riegel:</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On behalf
of Lexicon Pharmaceuticals, Inc., we submit the following response to the
comment received on May 29, 2009 from the Securities and Exchange Commission&#8217;s
staff with respect to Lexicon&#8217;s preliminary proxy statement filed on May 22,
2009 (File No. 000-30111).&#160;&#160;Your comment and our response to that
comment are set forth below.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Proposed Amendment to Our
Certificate of Incorporation, page 4</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top" style="LINE-HEIGHT: 12.55pt;">
              <td style="WIDTH: 65px">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.</font></div>
              </td>
              <td width="945">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Please
      expand your disclosure on page 4 to state the price at which the shares
      under the securities purchase agreement will be issued and the number of
      shares that could be issued under the
agreement.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top" style="LINE-HEIGHT: 12.55pt;">
              <td style="WIDTH: 88px">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Response</font>:</font></div>
              </td>
              <td width="922">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
      will include the following additional disclosure on page 4 of our
      definitive proxy statement:</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top" style="LINE-HEIGHT: 12.55pt;">
              <td style="WIDTH: 123px">
                <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
              </td>
              <td width="887">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      price per share of each rights offering would be designated by Invus in a
      range between $4.50 and a then-current average market price of our common
      stock, and the number of shares to be issued in each rights offering would
      be determined by the dollar amount of the rights offering and the
      designated price per share.&#160;&#160;For purposes of illustration, if we
      were to conduct both rights offerings for the maximum dollar amounts
      contemplated by the securities purchase agreement at an assumed price
      equal to the $1.39 closing price per share of our common stock on the
      Nasdaq Global Market on May 29, 2009, we would issue a total of
      247,841,727 shares in the rights
offerings.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div>
          <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top" style="LINE-HEIGHT: 12.55pt;">
                <td style="WIDTH: 88px">
                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>
                </td>
                <td width="922">
                  <div align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
      requested by the staff, we are providing the following
      acknowledgements:</font></div>
                  </div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top" style="LINE-HEIGHT: 12.55pt;">
              <td style="WIDTH: 87px">
                <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
              </td>
              <td style="WIDTH: 36px">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
              </td>
              <td width="887">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">we
      are responsible for the adequacy and accuracy of the disclosure in the
      filing;</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt"><br></div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top" style="LINE-HEIGHT: 12.55pt;">
              <td style="WIDTH: 88px">
                <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
              </td>
              <td style="WIDTH: 35px">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
              </td>
              <td width="887">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">staff
      comments or changes to disclosure in response to staff comments do not
      foreclose the Commission from taking any action with respect to the
      filing; and</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt"><br></div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
        </div>
      </div>
      <div>
        <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top" style="LINE-HEIGHT: 12.55pt;">
              <td style="WIDTH: 85px">
                <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
              </td>
              <td style="WIDTH: 37px">
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
              </td>
              <td width="888">
                <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">we
      may not assert staff comments as a defense in any proceeding initiated by
      the Commission or any person under the federal securities laws of the
      United States.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Please do
not hesitate to contact the undersigned at (281) 863-3321 with any comments or
questions concerning this letter or the above-referenced registration
statement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify">
        <div>
          <div align="right">
            <table cellpadding="0" cellspacing="0" width="50%">
                <tr>
                  <td valign="top" width="38%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Very
      truly yours,</font></div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                </tr>
                <tr>
                  <td valign="top" width="38%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/
      Jeffrey L. Wade</font></div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                </tr>
                <tr>
                  <td valign="top" width="38%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jeffrey
      L. Wade</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Executive
      Vice President and</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">General
      Counsel</font></div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                </tr>
            </table>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 12.55pt"><br></div>
    </div>
  </body>
</html>





</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@`!`3$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8T+C`P`/_;`$,``@$!`0$!
M`@$!`0("`@("!`,"`@("!00$`P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H*
M"@H&"`L,"PH,"0H*"O_;`$,!`@("`@("!0,#!0H'!@<*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_``!$(`%H!
M%@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/WTHHHH`****`"@D#J:POB/\1_"/PH\(7?C?QOJJ6EA9IEW/+.Q
M^ZB+U9F/``KY:U#]J[QK\;-::/3WDTG1"^(+"&3YY%[&5A]XG^Z/E'OUKV,L
MR/&YI&52FK0CO)[>B[O^F>3F.<X/+I*G-WG+:*W]7V7](^NH=4TVXN#:V]]%
M)(/O+&X8CZXZ5-/-%;0O<3-M2-2SMZ`#)KS?X&8,*]?N5Z!KO_(#O/\`KTD_
M]!-<&+PZPU=TT[V.["UWB**FU:YYC\*_VY?V5/C;XWA^''PM^,%GJ^MW"2/#
M80V5RC,L:EG.7C5>`">M>L5^-W_!'_\`Y/\`=&_[!^J?^D[U^R-<\E9G2PHH
MHI""BBB@`HHHH`****`"BBJNNVE[?Z)>6.F7AM[F:UDCM[@#F)RI"M^!P?PH
M`JV/C?P7JFO7'A73?%^EW&J6BYNM-@U"-[B$>KQAMR]1U%:E?DU^Q]^P!^VW
MX$_;8\/>*?%G@G4]*M-#\1?;-;\3S72M!=0!B9=D@8F;S@2N!D_O#N`P<?K+
M3:L-A1112$%%%%`!1110`4444`%%%%`!1110`4444`%&1ZU@?$@$^&78'I,I
M_G7C6NWM[;;FM[N6,CH4D(/Z5Y>.S-8*5G&_S_X!S5L1[%['T)D'H:*^6+WX
MH_$70"7TKQEJ"!3PCW!D4?\``7R*FTK]M'XA>&90OB72++5X%^^0#!+^#+E?
M_':\A<7Y9!VK*4?.UU^&OX',LTPZ=IW1X%^W_P#M%:M\6/CW=_#2PFDBT+P?
M=O9I;Y($]XO$TS#O@Y1?0*2/O&IO@7T@_"OFWQW^T5\./B1^U/XXMK74CI]_
M<^+KUDL+\A&8F9N$;.US[`Y]J^DO@7T@^@K^GLOQ.4XGA:B\NJ1G#E6L6GJT
MF[]G=W:=F?D<\15Q6>U*E1W;D_NO9?@?9WP,&(E_W*]`UW_D"7G_`%ZR?^@F
MO/O@:3Y2@_W*]!UW_D"7G_7K)_Z":_'<U_WV1^O99_N<3\>/^"/_`/R?YHW_
M`&#]4_\`2=Z_9&OQN_X(_?\`)_FB_P#8/U/_`-)WK]D:X)[GHRW"BBO/OVI_
MCIIW[-OP"\3?&:_@69M'T\M9VSG`GN7(CAC/L9&7..@R>U2(ROVE?VU/V>/V
M3[".;XN^-EAO[B/?9Z'I\?VB]N%YY$2GY5X(WN57(QG-?,<__!>WX&KJODVW
MP0\6/8[\?:7N+99=OKY8<C/MO_&OFW]@3]G'6/\`@HQ^TUK_`,3OV@];O-4T
MK3&6_P#$<AG97OYY&(AM0PYCCPK9"XVI&%&W((_4&+]DK]E^#PJ?!47[/G@T
M:88O+-K_`,(Y;8(QC).S);ONSNSSG-6U%:,>B,W]F']L[X"?M<:)-J?PC\4.
M]Y9J&U'1=1B$-[:`]"T>2&4GC>A9<\9SQ7?>//'O@[X8>$;[QYX_\0VVE:/I
ML/FWU_=OMCB7(&3ZDD@`#DD@#FOR8_:1\%W/_!+[_@H%I/B[X27%Q!H$PAU2
MQLFE9MUA+(T=S9L3RZC8X!.3C8<EAFOUJO;#PQ\1_!KZ?JMA;ZCI&MZ=MFM[
MA`\=Q!*G*L.X*M^M)JP-'C?[-_\`P46_9Q_:F^*6K?"GX7ZM??;-.M1<6=QJ
M5I]G34XP2)&@5CO.SY20ZJV&SC`)KWBOQA_;!_9M^)?_``3<_:<TWQ_\,+^Z
MAT9]0.H>#=9Y.S:<O:2G^)E!VD'[Z,#W('W!XY_X*O\`PQT[]B:U_:#\,RVS
M>*]61M.L?#3R;GM]45!YF\=3#'N$F[^)60<%N!Q[!8[[XX?\%*OV9_V??CC:
M_`KX@ZOJ/V^6V22^OM.LOM,&GNY'EQ3!"9-S*=V%5B`5R!FO?+6YBO+6.\@W
M;)8PZ;T*G!&1D'!!]CS7YK?\$I?V+?$'QI\=S?MO?M$137Z2:C)=>'HM17<V
MHWI<E[UP>J(V0G8L,CA!G]+>G2E)):"9\W?"/_@J7^S;\:/C99_`3PCI/BI-
M;O;V>UADO=,A2W#Q*[-EEG8@8C;'R^E?2-?C!_P3X_Y2;>'O^QFU3_T3<U^O
M?Q@^)_AWX+?"[7OBMXLD*Z?H.F2WEP%^\^Q<A%_VF;"CW84Y*S&T9?QT_:0^
M"G[-GAD>+/C-X^L]&MI"1:Q2$O/=,.JQ1("\AZ9V@@9YP*^3O%7_``7D_9\T
M[4'MO"'PB\6:I`C8%S=-;VH?W5=[G'UP?85\A_"KP;\9?^"KO[8$]SXX\230
M6\BM=ZK=("\>D::C@+!`IX!RP11W9B[9^;/ZB?"?]@;]D3X/>'X=!\-_`CP[
M>,D8674-<TR*^NICW9I9E8\]<+A?0#I3:4=PT1YG^SQ_P6`_9=^/'BNR\`ZA
M;:UX5UG4KA+>PBUFV1[>XF<@+&LT3-@DG`WJ@SQGFOJTD#J:\JL?V(?V4=(^
M)^E_&+P_\#M"TKQ!H\S2V-UI-H+6-7*E=[0Q;8G89R&*D@X((->#?\%B_P!L
M;Q#\`_A?I_P>^&^KO9>(/&,<INK^WDVRV>GIA7*$<J\C'8&Z@*^,'!$V3>@;
MG=_M'?\`!5;]D_\`9TUJX\(7?B"]\3ZY:N4N=,\,0).+=QQMDF=UC4@\%0S,
MN.5%>2^'?^"]'P#O=46V\3?!SQ7I]HSX^U6TEO<%1ZE"Z<>N"3]:Y+_@D]_P
M3D^&7C/X;6_[2WQ]\*0:[)JLSGPWHNI1[[:.!&*&XEC/$K.RMM5@5"@'!+#'
MVAX^_8[_`&7/B7X9E\)^*_@+X6DM9(BB/:Z+#;S0#&,QRQ*KQGW4BG[J8:&C
M\"/VD?@M^TMX5/B_X,^.K76+:,A;J%,QW%JY'"RQ.`\9ZXR,'!P2.:[AB%4L
M>PK\8_BSX?\`B=_P2C_;:$OPVU^YFL(A'>Z;Y[X75=+E8[K:<#`8@HZ$XX9`
MX"G&/U_^&OQ!T#XL?#?1?B9X6F+Z=KVE0WUH3U"2(&"MZ,,X([$&AJP-6/"_
MA#_P5-_9I^-7QGM?@7X4T[Q/!K%U<7,23ZCIL,=LA@CDDD+.)V(&V)L';Z=*
MPOCM_P`%C/V2/@[J\_AKPY>ZGXTU"W<I,?#D*-:QN.H-Q(ZJ_P!8]X]Z_+;P
M7\._%WQ=_:;3X6>![][34O$7B>?3H[A'91''+*Z2LVTY*",N6'=01WK]BO@7
M_P`$\OV3O@3X0MO#FF?!_0]:O$A5;W6_$6F17EU=/CYG+2J?+!/\"!5'IWIM
M10-)'B/PZ_X+I_LT^)M:BTKQ[X!\3>&H9G"_VBT<5W!%_M2"-A(!_NHQ]J^S
M/"WBKPWXW\.V7B[PAK=MJ6F:C;K/8WUG,)(IHV&0RL."*^#O^"M'_!/SX,Z-
M\#[W]HOX->!K#PYJOA^>%M8LM'ME@MKVUDD6(MY*`(DB,ZMN4#*[\Y.W$O\`
MP0;^+NM^(/AKXS^#.K7LDMKX=U"VOM)61L^5'="42QKZ*'A#X]96/<TFERW0
M6TN??E%%%2(P_B(N[PK.?[K(?_'A7B?B+[K5[AX]7=X3NQCLI_\`'Q7AWB+[
MK9KY;/\`XUZ?YGFX[<X+Q-]UOQK@/$_W7KO_`!-]UOJ:X#Q/]UZ_,<U^"1\_
MB#\C_P!I(LO[27C0HQ!'BB[P?3]ZU?;/_!+KXX>,?&FH3?#CQ5=&^CL+`7%G
M?3,3,JAU0QL?XQ\P()Y&,<\8^)?VD\_\-)>-L?\`0T7?_HUJ^J/^"2@Q\6M1
MQ_T`3_Z.BKZ?@C,L?@N,<'2H5'&-2T9I/22Y+V:V>NW9['Q%%)XR3?=_F?L)
M\#,>4N#_``5Z!KO_`"`[S_KTD_\`037G_P`#>(E''W*]`UW_`)`EY_UZR?\`
MH)K]AS7_`'V1^LY9_N<3\>/^"/\`_P`G^:-_V#]4_P#2=Z_9&OQA_P""3WB/
MP]X5_;JTC6?%&NV6FV:6.I*]U?W20QJ3`X`+.0`2>.M?KE_POGX&_P#19_"?
M_A16W_Q=<,]ST6=97R#_`,%N+F]@_8J$5JS!)O%]@ER!W39,PS_P)5_2OI+_
M`(7U\#/^BS^$_P#PH[7_`.+KRW]N'P/X:_:[_9(\9?#_`.%OB?2]>U2UM8[Z
MPBTK4(K@BXA;S4C/EL<%PCH,]VJ5HQ+<_.?]@/X<?\%"?$G@O7M?_8P\7PZ7
MIK:HEOK2F^M8FDG2,,A(F5C@+)P1QR:]]_X5%_P7:_Z*Q%_X-M-_^-UY7_P1
MT_:V\._L_?%S5?@]\3=333=&\8-$MO>7;;([34(R502$\(KJQ0D]&5,\9-?K
M8KHZAD8$'H0:J3:93>I^47QI_P""=G_!5#]HC6+/Q!\:)M-UZ\T^V-O9SW.N
MV:&*(L6*CRPH(R2>:_3KX->'=;\(?"'PKX3\2JHU'2_#EC:7X60.!-'`B/AA
MU^8'GO6WJFM:-HD*7&M:M;6D<DZ0QO=3K&&D=@J("Q&69B`!U).!4?B+Q#H?
MA/0;SQ1XDU6"QT_3[9[B]O+F0+'#$BEF=B>@`!-2VV*]SQ/_`(*36_P#G_9)
M\2_\-!OLTY8,Z2\`4W0U'!\C[.#UDW<$=-F_=\N:_%OX6S>`+?XCZ%-\6+6]
MG\,IJL+:Y#I[A9GM=X\P(3WVY]_0@\U]3?'7XK?%#_@K1^U_I?PF^&1N+7PC
M87+II*2H=EK:*1Y^HSK_`'V&,`]`40<DD_5O[:7_``2V^'_CO]F+2/"GP)\/
M16?B;P'II30G``?5(AEY8)FXW/(Q9U8])&/0,:M>[HQK0^K?ACJ'@'5?AYHN
MH?"R:R?PY)ID)T5M.`$`MM@$80#H`N!CMC%;M?D__P`$J_V^+_\`9V\:_P##
M-?QMU"6V\+:C?M%83WQ*G0[XMM97W?<B=N&!^X_S<`O7ZOHZR('1@01D$'J*
MAJS$U8_&'_@GS_RDX\/_`/8S:I_Z)N:^^?\`@LCJFI:=^PIK\6GLP6[U?3H+
MHK_SS^T*WY%E4?C7P-_P3Y_Y2<>'_P#L9M4_]$W-?J9^VO\`!&Y_:)_9>\7_
M``GTV-6O[_3#+I:MT-U"RS1#VRZ!<^]5+XD'5'QS_P`$`].TPV7Q-U8HIO!+
MI<(;N(B+EL?0D#\J_1FOQQ_X)3?M/Z7^RG^TG>^$OBE<G2M%\3Q#2]5FO!L7
M3[R.0^5)+G[@#%XV)^[OR>%-?L7;W$%U"ES:S))'(H9)(V!5E(R"".HI3^('
MN/K\AO\`@M]?7]S^V;;VEVS>3;^#K);53TVF6=B1_P`")_*OUTNKVSLE5[V[
MBA5Y%C0RR!0SL0JJ,]220`.Y-?G1_P`%W/V?]6NV\+_M)Z)8/+:VMN=%UV1%
MSY(+M);N?12SRKGIDH.]$/B!;GVK^QY86&F_LG_#6UTV)4B_X072GPG3<UI&
MS?\`CQ->CU\K_P#!([]I#P[\9?V5](\`2:K'_P`)#X)@&FZC9,X\PVZD_9Y@
M.I0QX3/]Z-O:OJ=F5068X`[FD]Q'YG?\%^[#3XO&GPTU.)%%U-I>IQS$=3&D
MEN4S^+O^M?4?_!)Z^U"__8#\#OJ#,QCCOXH6;J8UOK@+^`Z?A7P-_P`%5_C?
M;_M4?M@6G@'X3.VLVN@0QZ%I?V+]X+V^>4F7R\?>&]EC!'4QY&017ZE?LQ_!
M]/@%^SQX3^$&]6ET/0XH;QT/RO<D%YF'L96<CZU3TBD-['Y/?\$[$1_^"FOA
ML,N0/$6K$9]?LUU7[/U^,/\`P3J_Y2;>&_\`L8=6_P#2:ZK]GJ4]PEN>(_\`
M!2(`_L-?$G(S_P`4\?\`T;'7QW_P0%_Y'7XD_P#8+T[_`-&3U]B?\%(?^3&O
MB5_V+Q_]&QU\=_\`!`7_`)'7XD_]@O3O_1D]-?`Q_9/TRHHHJ"3+\9KO\+W@
M_P"F6?R.:\*\1XVM]17O/BI"_AR]`_Y]G/Y*37@WB/&UOPKYCB!:Q]#SL=NC
M@O$WW6_&N`\3_=>N_P#$W1OQ_G7`>)_NO7Y?FOP2/GL0?D=^TID?M(^-<=?^
M$HN__1K5]4_\$DUW?%S4`H)SH)P!_P!=HJ\#\;?!OQC\9_VL_&VB^%K7$,/B
M:[>_OY0?*M4\YN6/<GG"CDX]`2/TM_X(V?`WP1\+OBOJL.G60N[U/#+;]1NT
M#2%O/BSM[(/8?B33R3/,'EW'.6TF^:=X^ZO\'5]/S\CYG+,OJXS'.VB;>OS/
MMOX+:-JME:)<7FG31(4^5I8RN?SKNM3MY+S3;BTB(W2P.BYZ9((J?`'045^_
M8G$/$UG4:M<_4</06'I*"=['Y'W7_!#O]L>:YDF7Q!X&P\A89UJYSR?^O:F?
M\../VRL?\C#X&_\`!W<__(U?KG7+_&OXFVOP8^$GB+XL7NE27T/A[29K^6SB
MD"-,L:EBH8@@$XZUCSR.B[/RT_X<<?ME?]##X&_\'=S_`/(U?8'_``2V_8C^
M,/[&VG>,;3XM7^B7#:]-9O9'1KV28`1"4-OWQIC[XQC/>OJ+PAXAC\6^$]+\
M5PVS0IJ>G07:0LV3&)(U<*3WQNQ6C0Y-A<^*/VW?^"/?@_X_^)KWXJ_`[Q%:
M>%O$=^[2ZEIUY"QT^^F/)D_=@M`Y/+%58,>=H))/C'A+]FC_`(+:_!/34\"_
M#?QE=SZ3`/+MO*\4V%Q!"@X`C%XV^-1V"J,>E?I]10I,+GYY?#__`()9?M=_
M'/QCIWCW]MO]I;43#I]REQ;:7IVL27=U&ZD'".P$-L<C.Z,/]!UKZ7_;X_9>
M^)O[4OP#;X5?#3XIC0IDE66YM[R(M%JP0?+#-(GS1KNPV0&!(&5/;W:BE=BN
M?-__``3<_8:M/V.OA3)-XKAMI_&NOD2:_=PL'6W0']W:QMW5>I(^\Q/8+CZ0
MZ]:**&[L#X+_`."BW_!*/Q%\>?BS8?%K]G6#3;*^URZ$7BZVO9Q#`C8XOA@$
MDG&UU4%F.U@"2QKZX_9I^%'BWX(?!/0OA=XU^)%QXKO](M!`=8N;<1ED'W8P
M,DE4&%!8EB`,UWE%%VU8+GPS^S;_`,$D_'?P,_:KTW]HC4_C#I%_:V.JW=V^
MFP:;*DCB9)5"ABV,CS!V[5]S444-MA>Y\>_MR_\`!)3P%^TWX@NOBI\+-?@\
M*^+;KYK]9;<M8ZE)_?D5/FBD/>10V>ZDG-?//A/]C_\`X+-?`"S'@[X2>-;N
M;28/EMX=.\86LEI&O_3..\93&/8*/I7ZD44U)VL.Y^=GP]_X)I?MW_''QMI7
MCG]L/]IG4+&VTB^CN[.QM-9>]NHI48,#$HQ;V[9'WUWG_9-??GC/P+X5^(O@
MV^\`^.]'AU72M3M&M]0M+M`5G0C!SC&#W!&"#@C!`K6=E12['``R363X%\=^
M$?B7X7MO&G@378-3TJ\,@MKZV)*2%)&C?&?1T9?J#2;;"Y^>'Q2_X(\?M"_!
M7X@O\3?V'OB^\(1V:TLKG5'LM0M5)_U2S*/+G3M\Y3(P"&Y)SM=_9N_X+=?&
M336\`_$/Q[<V.DW"^5<RS^*+&"*2,\$2&R)E=2.H(.1U!K](+_QMH6F^,M/\
M"70N_P"T-3M)[BU\O3YGAV1%0^^95,<;?.N%9@6YP#@XUZ?,PNSY+_8/_P""
M5O@+]E#58OB=X^UN'Q/XT2,BUN4@*VFF9&&\A6^9W()'FM@X.`J\Y^LW!*$#
MN*6BDVV(_/']DO\`X):_M(_!#]LG2/CYXQU;PM)HECJU]<S1V.IS/<;)H9T3
M"M`H)S(N?F]>M?H=17$0?&NRF_:.N/V=O[!E%S;^#(O$)U/SAY9C>[>V$6S&
M=P*;LYQ@T-MAN9W[7GPH\3_'/]FOQA\)/!DUI'JFO:4;:R>^E9(5?>K?.RJQ
M`P#T!KY__P""6_[!?QL_8U\1^+]4^+&HZ!/%KME:160T:^EF*M$\I;=OB3`P
MXQC-?9%%%W:P7"BBBD!4UY/,T.]0_P`5I(/_`!TUX#XDZ./<5]"W<`NK66V+
M8\R-ESCID8KA+_X#66H`B7Q%*I/=;<?XUXF<8+$8M1]DKG)BJ4ZMN4^>/$WW
M6_&N`\3_`'7KZBUW]D\ZBC?8O&^QCT66PR/S#_TKS;QU^QM\6(8I)=!FT[4Q
MCY8X;DQR'\)`%_\`'J_.\VX?SCV4FJ+?I9_@M3P\1@L5;2-_0^0KKP5X;\&C
M46\/Z<D+ZIJ,]_?R]6FGE;<S,>_7`'8`"OH#_@EY_P`EIUO_`+%I_P#T?#7E
MOQB^'7COP!.;;QEX3O\`3BQ(1[FW(1S_`++_`'6_`FO4O^"7G_):=;_[%I__
M`$?#7XSPW3Q%+Q/P<:R:ESZIW3^%]]3'`P=/%PBU;4^Z:RO'&F>*=9\(:EI7
M@GQ+'HVKW%G)'IVJRV:W"VDQ4A9#$Q`<`X.T\&M6BO[%/K3XE^#GQ_\`VI9?
M!GPG_:-\;?&U-7L_B)X_3P]JO@P>'[:"SM89'N(TD@D1?.#J;?=EG8-OP1@<
M_0?[=7_)G'Q,_P"Q-OO_`$4:^1/@=\0O`OB_]G;]G+X->%/%NG:GXKL/B['J
M&H^']/NTFN[.UAGOGDFFC0EH5"NK9<#(;(S7UW^W4?\`C#CXE_\`8FWW_HIJ
M;W`\<_9O\9?M5>&?C7\*O`GQ<^*NGW6C^*_AW=ZA_P`(MI&B0Q6^G"WBMA`O
MGL&FE?;)ECN"[L@#')^J_%%CJNI^'+[3M#\1-I%Y/:R):ZHD"2M:2%2%E"2`
MHY4\X8$''-?-FD'_`(RP^``/_1(-2_\`15E6_P#\%'IM.'PD\)Z?XLOGM_"M
M]\2]'MO&CM<-%`=+9I/,6=U(VPEQ$&)('3)H`UOV5?B9\3]6^(OQ%^"/Q0\=
M6GBN?P3?V!L?$]OIT=I)>07=MYP26*$^6&0@KN0`'T%9O[:'C[]H?P%XM^'V
MG?!3XAZ3I-OXS\0IX;NXM4T(77V::8&1;U&WKEHUC=1&?D;=SVQP_P"PWX@_
M9S\-_M=?&3X:_`[5?#UOIMRNCSZ'I^A2(;>=(;7;<M"4^1]LL@#;2<%N:[K]
MMH_\5U\#>?\`FL5A_P"D]Q3ZCZGL'@7P[XR\.>"+?0/%_P`09?$.L11.)M>N
M-.AMVF8DE6,,(5%V@@8`&=O/)-?%GB7XQ?MKZ1\(OB=\9I_VGHOMOPR\:OX;
M@TFV\'V:V6I(DT,+7$H96D61O/#`*X52F,$$U]X5\%_$4C_AD7]I_G_FMES_
M`.EUC20+<]S^!'BCXV^"/VGK[]GSXG?&"?QO8W/@"'Q'::GJ&D6UI<6LYNO(
MDA'V=55HS]X!@2O3)KVCX@Z3X@USP=?Z5X5\<R>&M0FB`MM<BM(9VM"&!+B.
M8&-N`1A@1SGM7C.C$'_@HZ,?]$/C_P#3I6;^WXO@_4/&'PB\.?%^]AB\`ZCX
MSG3Q2FH71AL9F6SE:U2Y?(7891D*YVDCFCJ([#]COXI?$/X@:)XP\*_$[Q'9
MZYJ?@OQK=:'_`&_96:VXU**-(Y$F:)"41\28(7Y>.`*H?'[QG\:-?_:#\)?L
M[_"3XCP^#X]5\.ZAK6JZ^NCPWUP4MY(8D@BCG!C7)ER6()PH`Q7#?\$V_%GP
M3B\3_%[X:_"+5](6TM?B'<WNDZ;I++Y7]GM%#$DT.WY7BWQNNY<C(]QGHOC5
MXW\(?#+]O'P#XN^(GB6QT/2;CX>:W9PZIJMTMO;&X^T6LGE>8Y"AMBLP!.3C
MBBVH'JOP&T#XS>&?AQ;Z/\?/&]EXB\21W=SY^K:?;I%'-`9F,&42*)581;`P
M"XW`\GJ?FKXO?'/]I:*W^+OQV\(_&,:3I7PJ\61Z7I_@Q="MIK74X4%N9FN)
MG4S;G\XX*,NS:,9SFOISX*?&+PM\>OAY:?$_P3:7\6E7\LRV3ZA;B-YDCE:/
MS5`9@8V*EE;/*D'CI7Q+XTT;X`Q>+_CO9_M`?&KQKI/F_$8;?A_X9\0102ZW
M#/';>0\=G(,W)9OX@<83VH6X'WPVH2S>'3JL8\MWLO-4#G:2F?QKY?\`!'[2
MOQIUCX"_L^>-M1\8"34O'7CR'3?%%Q_9]N/MELPO"4"B/;'_`*J/E`I^7KR<
M_3SVX7PR;2UAE`%B4CCD'S_<P`<=Z_/OPO\`'3X/^$_V<_V;/#?B+XBZ5::E
MX7^)J/XDTV2[7[1I:1&]21KB(?/$JM(@+,`/F!SBA#1]^>/=(U_7O!NI:/X6
M\62Z%J%Q:LEIJ\-I'.UJ_P#?$<H*/]&!%>#_`/!*_0/%>D?LBZ+?:_X[FU:U
MO+N_;3K&6PAA&GJM_<HZJT:AI-[@R$N25+8'``KZ)EFBN-/>>"171X2R.IR&
M!'!!KQ#_`()J'/[%OA#_`*[ZK_Z=+NCH(T/&7C_XD:#^W!X)^'5IXR8^%_$7
M@W5;F[T,V$&%NK5X=LPFV>;R)\%=VWY!QR:U?VROB[XL^!O[.VN_$3P*EJ=8
MAEL[33Y+V,O%#)<W45N)64$;MGF[MN>2N#7,?$_'_#PCX4_]B-XE_P#0[*D_
MX*5QRG]CSQ'=)"[1VFHZ1<W+(A;RX8M3MI))#CHJHK,3V`)HZ@=%\&/AU^U)
MX)^(]]<?%O\`:!MO&OA:;0HEL4ET.VL;J#4?-)D;9;PJ##Y>W;F1FR3E>`3U
M/QF\.^//$GA'['\._C"W@B_CG$G]L#2K:\#(`P\IH[@%=I)4DC#?+@$9K,^'
M'[3/PE^+OQ(U3X:_#+7EUV31=(MK^_UK2I8KC3T\]G"0>=&YS-A"Y3'"D'.>
M!XO^U;:_!O7OVS/!_AW]J.[TL>!T^'VI7>EVWB:\$.FR:LMS"&8[V$;RK`6P
M&S@'(&:%<#UG]C;XO^*?CK^SEX>^)7C:.T&K71N[:_>Q0K%+);7<UL954D[0
M_E;\9XW8KE;'_E)MJ)_ZH=:_^G>>L?\`X)4^,O`WB']D32_#?@_6+::30M7U
M.&]LH>&M1+?W$\(*D`A6ADC93T(/'0XF\0>+_"W@#_@I=#>>.?$%GH\'B#X0
M0:=H=QJ=PL$=]>)JLC-;Q.Y`>7;(AV`[CN&!0,[3]MWXM>,?@A^S-XB^(_@*
M\@M-4M'LX(+^YMO.CLEGNX8'N60\-Y:2-)@_+\G/&:9^SUH/Q]\-^)M2MO'?
MQC@^('@V^TFTO?#7B6:VMH;L3ON\V(BU18Y(2NR1'QGYBN2`#74_'SXG^"?@
MY\)=7^(7Q(T2ZU#0;.../5;:TLEN"8)I4A9FC<A3&HDW/D\(&.#C%>)?L<ZA
MX,\+_M(>.?@Y^S_X^76_AE9>'[#5M/L[/4$O;+1=1N9I_-M;>9<[(V1%D$.X
MA2QQCD4=!'T]1112`****`"BBB@"MJVC:1KVGRZ3KFEV]Y:SKMFMKJ!9(W'H
M58$'\:X+X<?LO?"_X2?$J\^(_P`/+&;3FU#3VM;G34EW6XS(C[T!Y0_+C`.W
MG@#%>C45PXG+,OQF(IUZU*,ITW>,FES1?D]U^3(E3A*2DUJ@H.<<445W%GD_
M['/[."_LV?!+2/`&O6VC7.NV0N%O]7TRUQ]H#W$DJ@NR*[85E'/I7J5_I]AJ
MME+INJ6,-S;SH4FM[B(.DBGJ&4\$>QJ:B@"H-!T-;NWU!=&M!/9PF&TG%NN^
M",XRB'&54X'`XX%/U32M+US3YM(UK3;>\M+A"D]K=0K)'(IZJRL""/8U8HH`
MS?#_`(.\(^$[2&P\+>%=-TR"W1DMX=/L8X4B5B"P4(`%!(!('4@5:OM(TG5)
M()M3TRWN'M9A-:M/`KF&0<!U)'RMR>1SS5BB@`K/E\*>%I[.ZTZ;PUI[V]].
M9KV!K-"EQ*2#O=<8=L@')R>!6A10!772-)34O[932[<7GD>1]K$"^;Y6<[-V
M,[<\XSC-1Z]X=\/^*M+ET/Q1H5GJ5E.,3V=_:I-%(,YPR."#SZBKE%`%+1O#
M?AWPY;1V?A[0+*PABA6&**RM4B5(U)(0!0`%!)('09/K47B?P=X1\;:>-(\9
M^%=-U>T$@<6NJ6,=Q&&'1ML@(R/6M*B@".UM+6QMH[.RMHX88D"111(%5%`P
M``.``.U9VH>!/`^K>(;;Q=JG@W2KG5K-<6FJ7&G1/<0#T20KN7\#6K10`8&,
M8XK&B^'/P]@UJ[\20>!-&34;]-E]?II<0GN%])'V[G'`X)/2MFB@`P"-I`QZ
M57TS2M+T2R33=&TVWM+://EV]K"L:+DDG"J`!DDGZDU8HH`KRZ5I<^HQ:O/I
MMN]W;QLD%T\*F2-6QN56QD`X&0.N!4MQ;V]W`]K=P)+%(I62.10RLIX((/44
M^B@#-\+^#/!_@>Q;2_!?A/3-'MGD,CVVEV$=O&SGJQ6,`$GUI/%'@OP=XXL4
MTSQIX3TS6+:.421V^J6$=PBN.C!9`0"/7K6G10!!9:9INFJR:=I\%NKD%A!$
M$!(4*,X'954?0`=JAUCPWX=\1>1_PD&@V5]]EG6>U^V6J2^3*IRKKN!VL.Q'
M(J[10`RYMK:\MWM+RW26*5"DD4B!E=2,$$'@@CM5#POX-\(>"-/.D^"_"FFZ
<1:M(9&MM+L8[>,N>K;8P!D^M:5%`!1110!__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
